Evidence map›Paper›PMID 33242475›Full record

ArticleThe Lancet. Infectious diseases2021

A case of SARS-CoV-2 reinfection in Ecuador.

Belén Prado-Vivar, Mónica Becerra-Wong, Juan José Guadalupe, Sully Márquez, Bernardo Gutierrez, Patricio Rojas-Silva, Michelle Grunauer, Gabriel Trueba, Verónica Barragán, Paúl Cárdenas

Abstract readLetter
In one paragraph

Article in The Lancet. Infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Sequence Characteristics of Coronavirus Disease 2019 (COVID-19) Persistence and Reinfection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Article
  9. Article
  10. Article
  11. Article
  12. A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2022
    Review
  13. Review
  14. Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection Associates With Unstable Housing and Occurs in the Presence of Antibodies.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Belén Prado-VivarInstituto de Microbiología, Universidad San Francisco de Quito, Quito, Ecuador; Colegio de Ciencias Biológicas y Ambientales, and Centro de Bioinformática, Universidad San Francisco de Quito, Quito, Ecuador.
Mónica Becerra-WongInstituto de Microbiología, Universidad San Francisco de Quito, Quito, Ecuador.
Juan José GuadalupeLaboratorio de Biotecnología Vegetal, Universidad San Francisco de Quito, Quito, Ecuador.
Sully MárquezInstituto de Microbiología, Universidad San Francisco de Quito, Quito, Ecuador.
Bernardo GutierrezLaboratorio de Biotecnología Vegetal, Universidad San Francisco de Quito, Quito, Ecuador; Department of Zoology, University of Oxford, Oxford, UK.
Patricio Rojas-SilvaInstituto de Microbiología, Universidad San Francisco de Quito, Quito, Ecuador.
Michelle GrunauerEscuela de Medicina, Universidad San Francisco de Quito, Quito, Ecuador.
Gabriel TruebaInstituto de Microbiología, Universidad San Francisco de Quito, Quito, Ecuador.
Verónica BarragánInstituto de Microbiología, Universidad San Francisco de Quito, Quito, Ecuador.
Paúl CárdenasInstituto de Microbiología, Universidad San Francisco de Quito, Quito, Ecuador; Colegio de Ciencias Biológicas y Ambientales, and Centro de Bioinformática, Universidad San Francisco de Quito, Quito, Ecuador. Electronic address: pacardenas@usfq.edu.ec.

Funding

American Asian Centers for Arbovirus Research and Enhanced Surveillance (A2CARES)U01AI151788 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI Josefina Coloma, Eva Harris · 2020 to 2026
$9.6M
NIAID NIH HHS U01 AI151788
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19ReinfectionAntibodies, ViralEcuadorHumansMutationSARS-CoV-2Antibodies, Viral

Identifiers

PMID33242475
PMCPMC7833993

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.